What you should know:
1. The device can now be used for levels from C2-T1 in both anterior cervical discectomy and fusion procedures.
2. The clearance differentiates Nuvasive’s offering from other systems on the market that are only cleared for one- or two-level use.
3. NuVasive President Matt Link said the clearance is indicative of the company’s work to deepen its presence in the cervical market and deliver proper solutions.
Leonel Hunt, MD, an orthopedic spine surgeon at Los Angeles-based Hunt Spine, said, “The multilevel clearance provides surgeons a zero-profile interbody implant that can be used in more than two contiguous levels, enabling the surgeon to avoid supplemental fixation which can ultimately reduce operative time.”
More articles on devices:
Orthofix’s M6-C cervical disc in 2019: 7 key developments
Dr. Robert Brady: How the 2020 CMS final rule will affect the spine field
How OrthoNY is trying to solve its recruiting problem
